Development and cytotoxic response of two proliferative MDA- MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines
Cl\'emence Dubois (IMoST, IUT de Clermont-Ferrand), Dufour Robin, (IMoST, IUT de Clermont-Ferrand), Daumar Pierre (IUT de Clermont-Ferrand,, IMoST), Aubel Corinne (IMoST), Szczepaniak Claire (CICS), Blavignac, Christelle (CICS), Mounetou Emmanuelle (IMoST

TL;DR
This study developed 3D cell culture models from triple-negative breast cancer lines to better evaluate drug responses, revealing differences in sensitivity compared to traditional 2D cultures and highlighting their potential in preclinical testing.
Contribution
It introduces optimized 3D spheroid models from TNBL breast cancer cell lines, demonstrating their utility in assessing chemotherapeutic efficacy and tumor cell behavior.
Findings
3D spheroids were less sensitive to chemotherapy than 2D cultures.
Optimal spheroid formation used 1000 cells/well with 2% Geltrex.
Proliferative and non-proliferative spheroids can distinguish drug effects.
Abstract
Triple-Negative Basal-Like tumors, representing 15 to 20% of breast cancers, are very aggressive and with poor prognosis. Targeted therapies have been developed extensively in preclinical and clinical studies to open the way for new treatment strategies. The present study has focused on developing 3D cell cultures from SUM1315 and MDA-MB-231, two triple-negative basal-like (TNBL) breast cancer cell lines, using the liquid overlay technique. Extracellular matrix concentration, cell density, proliferation, cell viability, topology and ultrastructure parameters were determined. The results showed that for both cell lines, the best conditioning regimen for compact and homogeneous spheroid formation was to use 1000 cells per well and 2% Geltrex. This conditioning regimen highlighted two 3D cell models: non-proliferative SUM1315 spheroids and proliferative MDA-MB-231 spheroids. In both cell…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
